Supraplase 40 Kit Injection 1's belongs to the class of drugs called thrombolytics (clot-busting drugs) indicated to reduce the risk of death in people who have had a serious type of heart attack known as acute ST-elevation myocardial infarction (STEMI). Heart attack refers to blocked blood flow to the heart due to blockage of arteries. STEMI is a type of serious heart attack that mainly affects the lower chambers of the heart.
Supraplase 40 Kit Injection 1's contains Tenecteplase, a clot-busting drug that helps to dissolve unwanted blood clots in the blood vessels of the heart. Thus, it helps to prevent damage caused by heart attack.
Supraplase 40 Kit Injection 1's will be administered by a healthcare professional; do not self-administer. Supraplase 40 Kit Injection 1's may cause common side effects such as bleeding, nosebleeds, bruising, bleeding at the injection or puncture site, or blood in the urine. If you notice such side effects, please inform your doctor.
If you are allergic to Tenecteplase or any other medicines, please tell your doctor. Supraplase 40 Kit Injection 1's should be used with caution in patients aged over 75 years and who weigh less than 60 kg. Supraplase 40 Kit Injection 1's is not recommended for children below 18 years of age as the safety and effectiveness were not established. If you are a pregnant or breastfeeding woman, please inform your doctor before receiving Supraplase 40 Kit Injection 1's. If you have had a recent major surgery or trauma, inform your doctor.